Association of ABCB1 and MTHFR genetic polymorphisms with rheumatoid arthritis … – Frontiers
Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1660473. This article is part of the Research TopicUnraveling the Role […]
Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1660473. This article is part of the Research TopicUnraveling the Role […]
It was published online on September 16, 2025, in Arthritis & Rheumatology. LIMITATIONS: There was a predominance of White patients
Scleroderma-associated Interstitial Lung Disease Mbolster@mgh.h… Mon, 09/22/2025 – 08:00
QD Clinic: Stick or twist (when not to change treatment) tammytilley@gm… Mon, 09/22/2025 – 08:00 Rheumatoid Arthritis Anti-Rheumatic Rx Cardio/Pulmonary
DNA Cell Biol. 2025 Sep 22. doi: 10.1177/10445498251381257. Online ahead of print. ABSTRACT N6-Methyladenosine (m6A) is a reversible RNA modification
Wien Klin Wochenschr. 2025 Sep 22. doi: 10.1007/s00508-025-02622-7. Online ahead of print. NO ABSTRACT PMID:40982074 | DOI:10.1007/s00508-025-02622-7
Intern Med J. 2025 Sep 22. doi: 10.1111/imj.70212. Online ahead of print. ABSTRACT Glucocorticoid (GC)-related toxicity remains a major challenge
Rheumatology (Oxford). 2025 Sep 22:keaf504. doi: 10.1093/rheumatology/keaf504. Online ahead of print. ABSTRACT OBJECTIVES: This study aimed to identify predictors of
Audiol Res. 2025 Sep 12;15(5):116. doi: 10.3390/audiolres15050116. ABSTRACT Background/Objectives: This study aimed to: (1) evaluate the effectiveness of the Croatian
Reports (MDPI). 2025 Sep 17;8(3):180. doi: 10.3390/reports8030180. ABSTRACT Background and clinical significance: Paget’s disease of bone involves anomalies of the
Epidemiologia (Basel). 2025 Sep 2;6(3):52. doi: 10.3390/epidemiologia6030052. ABSTRACT Introduction: Patients with inflammatory bowel disease (IBD) are at increased risk of
Kidney Int Rep. 2025 Jul 3;10(9):2977-2990. doi: 10.1016/j.ekir.2025.06.047. eCollection 2025 Sep. ABSTRACT INTRODUCTION: This study aimed to evaluate the comparative
Discov Immunol. 2025 Aug 27;4(1):kyaf012. doi: 10.1093/discim/kyaf012. eCollection 2025. ABSTRACT INTRODUCTION: Factors regulating the severity of pneumonitis during viral infections
World J Diabetes. 2025 Sep 15;16(9):108480. doi: 10.4239/wjd.v16.i9.108480. ABSTRACT BACKGROUND: There are only a few studies on the influence of
Front Pediatr. 2025 Sep 4;13:1657533. doi: 10.3389/fped.2025.1657533. eCollection 2025. ABSTRACT BACKGROUND: The Wilms Tumour gene 1 (WT1, NM_024426.6) holds significant
Infect Drug Resist. 2025 Sep 13;18:4887-4900. doi: 10.2147/IDR.S540702. eCollection 2025. ABSTRACT OBJECTIVE: To investigate the distribution, drug resistance patterns, multi-locus
Case Rep Hematol. 2025 Sep 11;2025:9919411. doi: 10.1155/crh/9919411. eCollection 2025. ABSTRACT Intravascular large B-cell lymphoma (IVLBCL) has a high mortality
Clin Med Insights Case Rep. 2025 Sep 17;18:11795476251377952. doi: 10.1177/11795476251377952. eCollection 2025. ABSTRACT BACKGROUND: This report presents a unique case
Ther Adv Endocrinol Metab. 2025 Sep 17;16:20420188251378216. doi: 10.1177/20420188251378216. eCollection 2025. ABSTRACT BACKGROUND: Tirzepatide (TZP) has demonstrated efficacy for glycemic
Physiol Rep. 2025 Sep;13(18):e70567. doi: 10.14814/phy2.70567. ABSTRACT Patients undergoing long-term peritoneal dialysis (PD) frequently develop peritoneal fibrosis and angiogenesis, leading
Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43405. Online ahead of print. NO ABSTRACT PMID:40977498 | DOI:10.1002/art.43405
Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43399. Online ahead of print. NO ABSTRACT PMID:40977493 | DOI:10.1002/art.43399
J Cardiovasc Med (Hagerstown). 2025 Sep 1;26(9):477-486. doi: 10.2459/JCM.0000000000001757. Epub 2025 Aug 20. ABSTRACT AIMS: Bicuspid aortic valve (BAV) is
Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43384. Online ahead of print. ABSTRACT OBJECTIVES: The aim of this study was to
Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43401. Online ahead of print. ABSTRACT OBJECTIVE: To estimate the effect of time from
Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43398. Online ahead of print. ABSTRACT OBJECTIVE: The Phase 3 MANDARA study demonstrated non-inferiority
Arch Rheumatol. 2025 Sep 1;40(3):410-412. doi: 10.5152/ArchRheumatol.2025.11132. NO ABSTRACT PMID:40977374 | DOI:10.5152/ArchRheumatol.2025.11132